The Kentucky Network for Innovation and Commercialization (KYNETIC) has selected eight teams from universities across the Commonwealth for Cycle 8 project funding.
KYNETIC is a National Institutes of Health (NIH) funded Research Evaluation and Commercialization Hub (REACH) and part of the national NIH Proof-of-Concept Network.
The program offers entrepreneurial education and proof-of-concept/product development grants to accelerate the translation of academic innovations into biomedical products by investigators throughout the Commonwealth of Kentucky. The goal is to advance the most promising biomedical research innovations — including pharmaceuticals, devices and apps — from the state’s eight public universities and the 16 community and technical colleges in the Kentucky Community and Technical College System (KCTCS).
In this cycle, KYNETIC awarded grants of $56,250 to each selected team, including two KCV Partner Institutions:
New Award: Kentucky State University, Jamaal Jackson, Ed.D., “Cross the Finish Line: Strategies for Increasing the Retention, Persistence, and Graduation Rates of Black, Male Student-Athletes”
Renewal Award: Eastern Kentucky University, Jamie Fredericks, Ph.D., “Forensic/Clinical DNA Sample Collection Tool”
The KYNETIC program is led by the University of Kentucky, the University of Louisville, the Kentucky Cabinet for Economic Development and Kentucky Commercialization Ventures, an initiative of the Kentucky Science and Technology Corporation.